Comparison of generic and disease-specific scales
| Diagnostic group | Generic scale | Disease-specific scales | Relationship between the measures of generic and disease-specific scales | ||||
|---|---|---|---|---|---|---|---|
| Median SE of measures | Range of measures | Extreme subjects | Median SE of measures | Range of measures | Extreme subjects | ||
| (logits) | (logits) | (%) | (logits) | (logits) | (%) | R (p value) | |
| CS | 0.50 | 7.06 | 11 | 0.46 | 8.56 | 08 | 0.95 (<0.001) |
| CP | 0.53 | 10.87 | 09 | 0.49 | 11.98 | 11 | 0.95 (<0.001) |
| RA | 0.61 | 8.27 | 09 | 0.44 | 8.68 | 09 | 0.96 (<0.001) |
| SSc | 0.66 | 8.45 | 21 | 0.46 | 10.64 | 12 | 0.95 (<0.001) |
| NMDc | 0.70 | 6.78 | 23 | 0.53 | 8.12 | 15 | 0.94 (<0.001) |
| NMDa | 1.08 | 10.48 | 40 | 0.70 | 11.14 | 31 | 0.97 (<0.001) |
CP, cerebral palsy; CS, chronic stroke; NMDa, neuromuscular adults; NMDc, neuromuscular children; R, Pearson correlation; RA, rheumatoid arthritis; SE, standard error associated to subjects’ measure; SSc, systemic sclerosis.